• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


Catalent Pharma Solutions Invests $35 Million To Expand Its Winchester, Kentucky, Manufacturing Center

Catalent Pharma Solutions LLC will invest $35 million to expand its operations center and add 80,000 square feet to its current 100,000-square-foot facility on Enterprise Drive in Winchester, Kentucky, creating 90 jobs in the region.

The Winchester plant currently employs more than 300 people and produces a variety of over-the-counter and prescription drugs in tablet, capsules and powders. The facility has launched more than 100 products for Catalent’s pharmaceutical and consumer health customers. Catalent expects to complete the expansion of the facility by October 2014.

“Catalent is a fully integrated formulation, regulatory, and manufacturing solutions partner, helping pharmaceutical and consumer healthcare companies differentiate their products and reach markets faster,” said John Chiminski, president and CEO of Catalent Pharma Solutions.

“Catalent has been present at this site for over 20 years developing and manufacturing important medicines,” said Steve Havel, general manager of Catalent’s Winchester facility. “Our commitment to Kentucky is illustrated by the expansion of our Winchester facility, which will provide our customers with more capabilities to help develop and manufacture new products.”

“Catalent is making tremendous strides in Winchester, and we’re excited to see such success for a global company in the Commonwealth,” said Gov. Steve Beshear. “The numbers speak for themselves, with 90 new jobs and $35 million in investment, but this also shows the level of confidence that Catalent has in Kentucky’s high quality workforce.”

As an incentive to encourage the investment and job growth in Winchester, the Kentucky Economic Development Finance Authority preliminarily approved the company for tax incentives up to $2 million through the Kentucky Business Investment program. The performance-based incentive allows a company to keep a portion of its investment over the term of the agreement through corporate income tax credits and wage assessments by meeting job and investment targets.

KEDFA also approved Catalent for tax benefits up to $860,000 through the Kentucky Enterprise Initiative Act, which allows approved companies to recoup Kentucky sales and use tax on construction costs, building fixtures, equipment used in research and development and electronic processing equipment.

“Catalent is another prime example of the commitment by our existing industry to invest, grow and continue to hire highly skilled people,” said Winchester Mayor Ed Burtner. “Catalent has quickly become one of our flagship manufacturers, and we are proud they are making such a large investment here in their future and in ours.”

Exclusive Research